2 good meds to prevent breast cancer, study finds

Older women at higher risk for breast cancer now have two good drug options for preventing the disease, but they will have to weigh the trade-offs, a major study shows.

Tamoxifen, the longtime gold standard, is more effective and longer lasting, the results show. But a newer drug — raloxifene, sold as Evista — is safer.

“I don’t see a clear winner,” but two good choices with different risks and benefits, said Dr. Scott Lippman, a cancer specialist at the University of Texas M.D. Anderson Cancer Center.

He is editor of Cancer Prevention Research, a journal that today published long-term results from the federally funded study. They also were being presented at an American Association for Cancer Research meeting in Washington, D.C.

Tamoxifen is widely used to treat cancer once it’s diagnosed, and Evista is used to treat osteoporosis. But the drugs have not found wide acceptance so far as cancer preventives. Doctors hope the findings will spur more high-risk women to consider taking one of the drugs.

They’re not recommended for women at average risk of breast cancer. But for the millions who are at higher risk because of gene mutations, family history or other factors, they can make a dramatic difference.

Tamoxifen cut the chances of developing the most serious forms of breast cancer in half, the research shows, but with a higher risk of uterine cancer. Evista cut the cancer risk by 38 percent, with fewer uterine problems and other serious side effects.

“We’ve now documented that it’s far less toxic” than tamoxifen, said study leader Dr. D. Lawrence Wickerham. He is a cancer specialist at Allegheny General Hospital in Pittsburgh who has consulted for makers of both drugs.

Tamoxifen has long been used to treat and prevent breast cancer. It blunts estrogen, which fuels the growth of most tumors that occur after menopause.

Evista, sold by Indianapolis-based Eli Lilly &Co., more selectively blocks estrogen. It is only for use after menopause; its safety and effectiveness before then are unknown.

Generic tamoxifen costs about 30 cents a day, versus up to $3 for Evista. Both can cause hot flashes.

The study, called STAR, compared them in nearly 20,000 postmenopausal women at higher risk of breast cancer. They took one drug or the other for about five years and then stopped (longer use is not known to be safe or good).

After about seven years of follow-up, there were 310 cases of invasive breast cancer among women on Evista versus 247 in those on tamoxifen. That works out to a 24 percent higher cancer rate for Evista users.

Uterine cancer developed in 65 tamoxifen users but in only 37 women on Evista. Twice as many women on tamoxifen had abnormal uterine growths that led to hysterectomies. Blood clots and cataracts also were less common with Evista.

Evista clearly is the safer drug, said V. Craig Jordan of Georgetown University, the scientist who led development of tamoxifen. However, Evista’s breast cancer prevention benefits wane over time much more than tamoxifen’s do.

Lippman, the Texas cancer specialist, agreed.

“It may be that with raloxifene, you need to continue to take it,” he said. And even counting the additional uterine cancers that occurred with tamoxifen, its users still had 35 fewer invasive cancers overall than women on Evista.

It sets up a choice, he said. For example, women might choose tamoxifen if they are at very high risk of breast cancer and have had hysterectomies so that uterine cancer is not a concern.

Marty Smith, 55, an insurance agent in Grandville, Mich., has used both drugs. Her sister and mother had breast cancer and a grandfather had male breast cancer. She switched to Evista after two years on tamoxifen because of worries about side effects.

“I thought, if there’s something else that’s going to give me equal and possibly better breast cancer prevention with less risk, then I was going to get on it,” she said.

On the Net:

STAR study: www.cancer.gov/star

Cancer risk calculator: cancer.gov/bcrisktool

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Local News

Customers enter and exit the Costco on Dec. 2, 2022, in Lake Stevens. (Olivia Vanni / The Herald)
Costco stores could be impacted by looming truck driver strike threat

Truck drivers who deliver groceries and produce to Costco warehouses… Continue reading

Two Washington State ferries pass along the route between Mukilteo and Clinton as scuba divers swim near the shore Sunday, Oct. 22, 2023, in Mukilteo, Washington. (Ryan Berry / The Herald)
Ferry system increases ridership by a half million in 2024

Edmonds-Kingston route remains second-busiest route in the system.

Alina Langbehn, 6, center, and Vera A., 6, right, sit on a swing together at Drew Nielsen Neighborhood Park after school on Tuesday, Jan. 28, 2025 in Everett, Washington. (Olivia Vanni / The Herald)
Everett council votes to renovate Drew Nielsen Park

Construction on the $345,000 upgrade could start as early as this fall.

Northshore School District bus driver Stewart O’Leary pictured next to his buses shattered drivers side windshield on Friday, Feb. 14, 2025 in Bothell, Washington. (Olivia Vanni / The Herald)
‘Put me in, coach’: Bus driver back at work after struck by metal bar

Stewart O’Leary, a Northshore employee, has received national attention for his composure during a frightening bus trip.

Lynnwood councilor Joshua Binda speaks during a Lynnwood City Council meeting on Wednesday, Nov. 20, 2024. (Olivia Vanni / The Herald)
Does the Lynnwood Council VP live in Lynnwood? It’s hard to say.

Josh Binda’s residency has been called into question following an eviction and FEC filings listing an Everett address. He insists he lives in Lynnwood.

Robin Cain with 50 of her marathon medals hanging on a display board she made with her father on Thursday, Jan. 2, 2025 in Lake Stevens, Washington. (Olivia Vanni / The Herald)
Running a marathon is hard. She ran one in every state.

Robin Cain, of Lake Stevens, is one of only a few thousand people to ever achieve the feat.

People line up to grab food at the Everett Recovery Cafe on Wednesday, Dec. 4, 2024 in Everett, Washington. (Olivia Vanni / The Herald)
Coffee, meals and compassion are free at the Everett Recovery Cafe

The free, membership-based day center offers free coffee and meals and more importantly, camaraderie and recovery support.

The Everett Wastewater Treatment Plant along the Snohomish River on Thursday, June 16, 2022 in Everett, Washington. (Olivia Vanni / The Herald)
Everett water, sewer rates could jump 43% by 2028

The rate hikes would pay for improvements to the city’s sewer infrastructure.

The bond funded new track and field at Northshore Middle School on Thursday, Oct. 24, 2024 in Bothell, Washington. (Courtesy of Northshore School District)
Northshore School District bond improvements underway

The $425 million bond is funding new track and field complexes, playgrounds and phase one of two school replacements.

An American Robin picks a berry from a holly tree on Thursday, Feb. 13, 2025 in Edmonds, Washington. (Olivia Vanni / The Herald)
Calling all birders for the annual Great Backyard Bird Count

The Audubon Society will hold its 28th annual Great Backyard… Continue reading

A view of one of the potential locations of the new Aquasox stadium on Monday, Feb. 26, 2024 in Everett, Washington. The site sits between Hewitt Avenue, Broadway, Pacific Avenue and the railroad. (Olivia Vanni / The Herald)
Initial prep work for AquaSox stadium to start, with $200k price tag

The temporary agreement allows some surveying and design work as the city negotiates contracts with designers and builders.

Aaron Kennedy / The Herald
The Joann Fabric and Crafts store at 7601 Evergreen Way, Everett, is one of three stores in Snohomish County that will close as part of the retailer’s larger plan to shutter more than half of its stores nationwide.
Joann store closure plan includes Everett, Arlington, Lynnwood locations

The retail giant filed a motion in court to close approximately 500 stores in the U.S.

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.